Document is current
Any future updates will be listed below
-
Authors
Riedmayr, Lisa Maria https://orcid.org/0000-0002-0307-2507
Hinrichsmeyer, Klara Sonnie https://orcid.org/0000-0001-8284-1775
Thalhammer, Stefan Bernhard
Mittas, David Manuel
Karguth, Nina
Otify, Dina Yehia
Böhm, Sybille
Weber, Valentin Johannes
Bartoschek, Michael David https://orcid.org/0000-0003-4238-3970
Splith, Victoria
Brümmer, Manuela
Ferreira, Raphael
Boon, Nanda https://orcid.org/0000-0001-9756-8898
Wögenstein, Gabriele Maria
Grimm, Christian https://orcid.org/0000-0001-9318-4352
Wijnholds, Jan https://orcid.org/0000-0003-0099-460X
Mehlfeld, Verena
Michalakis, Stylianos
Fenske, Stefanie https://orcid.org/0000-0002-6994-8401
Biel, Martin
Becirovic, Elvir https://orcid.org/0000-0001-8801-0649
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (BE 4830/2-2, BE4830/5-1, MI 1238/4-1, FE 1929/1-1, BI 484/7-2)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030E_213089, 310030_212190)
- License Information
-
More Information
Article History
Received: 17 August 2022
Accepted: 10 October 2023
First Online: 18 October 2023
Competing interests
: L.M.R, S.B., V.S., M.Bi., S.M., and E.B. are authors on a patent application covering transactivation of homologous genes (PCT/EP2020/076536, filed by ViGeneron GmbH, status: published). E.B., M.Bi., and S.M. are authors on a patent application covering the splice site module and its applications (PCT/EP2019/086454, filed by ViGeneron GmbH, status: published). S.M. and M.Bi. are co-founders and shareholders of ViGeneron GmbH and members of its scientific advisory board. E.B. is a member of scientific advisory board of ViGeneron GmbH. The remaining authors declare no competing interests.
